申请人:Ozawa Michinori
公开号:US20100179118A1
公开(公告)日:2010-07-15
The present invention relates to a compound represented by the following formula (I), which is useful as an antiallergic agent and/or an anti-inflammatory agent, or a physiologically acceptable salt thereof and the like:
wherein R
1
and R
2
are the same or different and each is an optionally substituted aryl group and the like, R
3
is a hydrogen atom, a C
1-6
alkyl group and the like, R
4
and R
5
are the same or different and each is a hydrogen atom, a halogen atom, a hydroxy group, a C
1-6
alkyl group and the like, X is a single bond or —C(R
6
)(R
7
)—, R
6
and R
7
are the same or different and each is a hydrogen atom, a halogen atom, an optionally substituted C
1-6
alkyl group and the like, or R
6
and R
7
optionally form, together with the carbon atom bonded thereto, an optionally substituted C
3-8
cycloalkyl group and the like, ring group A is an azetidin-1-yl group and the like, m is 0, 1 or 2, and n is 0, 1 or 2.
本发明涉及以下式(I)所表示的化合物或其生理上可接受的盐等,其可用作抗过敏剂和/或抗炎剂:
其中,R1和R2相同或不同,每个都是可选取的取代芳基基团等;R3是氢原子、C1-6烷基基团等;R4和R5相同或不同,每个都是氢原子、卤原子、羟基、C1-6烷基基团等;X是单键或—C(R6)(R7)—;R6和R7相同或不同,每个都是氢原子、卤原子、可选取的取代C1-6烷基基团等,或R6和R7可选择性地与与其相连的碳原子一起形成可选取的取代C3-8环烷基团等;环基团A是氮杂环丙烷基团等;m为0、1或2;n为0、1或2。